Metastatic Thyroid Papillary Carcinoma
1 clinical trials · Condition
◉ Watch Metastatic Thyroid Papillary Carcinoma
| Record | Firm | Date |
|---|---|---|
| Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY Trial (NCT03753919) | Grupo Espanol de Tumores Neuroendocrinos | 2019-04-02 |
Track Metastatic Thyroid Papillary Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.